Organovo Holdings (ONVO) 4.45 $ONVO Premarket Gainers /

New Post Public Reply Private Reply Replies (0) Message Board

Mar 16, 2015 at 2:09 PM

Organovo Holdings (ONVO) 4.45 $ONVO

Premarket Gainers / Losers
Seeking Alpha - at Seeking Alpha - Fri Mar 13, 8:14AM CDT

HIBB: 48.90 (-1.93), WLL: 38.24 (-1.76), ANN: 41.46 (+1.01), AXN: 1.76 (+0.10), CBPX: 18.99 (+0.04), CTIC: 1.99 (+0.02), FXCM: 2.40 (-0.18), ARO: 2.96 (-0.10), GENE: 4.46 (-0.25), ONVO: 4.45 (-0.25), CYTX: 1.33 (+0.13), LOCO: 26.83 (-0.27), GALE: 1.38 (-0.04), ULTA: 150.30 (+0.20), CUR: 2.37 (-0.19)

Organovo says liver tissue will be $100M business
Seeking Alpha - at Seeking Alpha - Fri Mar 13, 7:49AM CDT

ONVO: 4.45 (-0.25)

Organovo Provides Market Update
PR Newswire - Fri Mar 13, 7:05AM CDT
Organovo Holdings, Inc. (NYSE MKT: ONVO; "Organovo"

, is providing the following market update:
ONVO: 4.45 (-0.25)

Is There Still Room For Shorting Organovo?
Akshansh Gandhi - at Seeking Alpha - Thu Mar 12, 2:49AM CDT

ONVO: 4.45 (-0.25)

Critical Alerts For Ballard Power Systems, Organovo, Micron Released By InvestorsObserver
PR Newswire - Mon Mar 09, 8:31AM CDT
InvestorsObserver issues critical PriceWatch Alerts for BLDP, ONVO, MU.
BLDP: 2.11 (-0.02), MU: 28.36 (-0.36), ONVO: 4.45 (-0.25)

5 Live Investor Webcasts from Aflac and Life Sciences Companies: March 5 at VirtualInvestorConferences.com
CNW Group - Tue Mar 03, 7:30AM CST
CEOs and top executives to take questions in real-time during formal roadshow presentations as well as meet and "chat" in virtual trade booths
RDHL: 13.53 (-0.11), ONVO: 4.45 (-0.25)

Organovo investor presentation set for March 5
Seeking Alpha - at Seeking Alpha - Mon Mar 02, 9:14AM CST

ONVO: 4.45 (-0.25)

Organovo Holdings Inc. Announces Ambitious New Plan
Brian Stoffel, The Motley Fool - Motley Fool - Sat Feb 28, 11:16AM CST
Organovo is attempting to dramatically increase its reach in the medical community. Photo: Organovo. . Organovo might be one of the most misunderstood 3D printing plays on the market. Many think the company is trying to strike gold by devising a...
ONVO: 4.45 (-0.25)

Organovo -4.2% after filing $190M mixed shelf
Seeking Alpha - at Seeking Alpha - Fri Feb 27, 6:14PM CST

ONVO: 4.45 (-0.25)

Seeking Alpha's Biotech Weekly: Achillion Overdone, Sanofi's Toujeo A Go, And More
SA Editor Mike Taylor - Seeking Alpha - Fri Feb 27, 3:00PM CST
Every Friday, Seeking Alpha's Biotech Weekly highlights the editors' picks of the week's Seeking Alpha analysis, as well as a review of the top Breaking News stories. See something here that deserves further analysis? We are always looking for new...
CYTK: 7.80 (-0.18), VRX: 201.73 (+4.30), ACT: 303.64 (+4.69), PCYC: 256.05 (+1.07), MDT: 77.62 (+1.15), CAH: 89.80 (+1.68), CLDX: 30.61 (+0.87), HSP: 87.58 (+0.02), AGN: 240.88 (+3.54), JNJ: 100.76 (+1.55), ATOS: 1.92 (-0.01), ONVO: 4.45 (-0.25), PTCT: 73.31 (+0.04), SNY: 48.66 (+1.59), PTLA: 41.41 (+0.71), INCY: 90.86 (+1.55), PFE: 34.46 (+0.46), CPHR: 10.80 (-0.75), MYL: 60.74 (+0.98), AMGN: 161.79 (+7.53), LLY: 71.12 (+1.23), BMY: 67.84 (+0.97), MNKD: 5.43 (-0.08), NKTR: 14.41 (+0.52), OMER: 24.00 (-1.21), DVA: 81.21 (+0.40), GILD: 101.03 (+1.42), SGEN: 39.04 (+0.73), ACHN: 11.19 (-0.11), MRK: 57.07 (+0.87), TEVA: 60.69 (+0.69), BIL: 45.72 (-0.01), ARIA: 8.68 (+0.20), NVS: 97.96 (+0.92)

Lessons From A Dozen Years Of Short Selling
Whitney Tilson - Seeking Alpha - Fri Feb 27, 9:39AM CST
(Editor's Note: Long-time contributor Whitney Tilson developed a presentation titled "Lessons from a Dozen Years of Short Selling" that he's presented at a handful of investment conferences in New York City. With his permission, we're now...
MBI: 9.26 (-0.12), FCEL: 1.25 (+0.01), HLF: 34.55 (-1.41), AFC: 25.60 (-0.18), VJET: 8.17 (-0.06), LL: 29.73 (-0.82), BLDP: 2.11 (-0.02), NSR: 21.94 (-0.32), TXTR: 25.04 (+0.22), RPTP: 11.43 (-0.45), LNKD: 258.91 (-0.21), ONVO: 4.45 (-0.25), XONE: 15.40 (+0.29), ARNA: 4.74 (-0.07), AGM: 31.28 (-0.88), PLUG: 2.77 (-0.09), FB: 77.66 (-0.39), DDD: 26.74 (-0.49), DECK: 71.23 (+0.54), TRIP: 82.86 (+0.34), CSLT: 7.80 (-0.05), LRN: 16.82 (+0.08), PCLN: 1,158.41 (+0.64), NFLX: 419.59 (-18.81), CROX: 11.70 (-0.17), CALL: 7.97 (+0.07), WRLD: 90.01 (-0.65), SODA: 18.19 (-0.10)

More dilution on the way for Organovo shareholders
Seeking Alpha - at Seeking Alpha - Thu Feb 26, 8:29AM CST

ONVO: 4.45 (-0.25)

3D Printing Notches Another Major Healthcare Breakthrough
Sean Williams, The Motley Fool - Motley Fool - Sat Feb 21, 8:12AM CST
There are few technologies expected to change the landscape of numerous manufacturing industries over the coming decade more than 3D printing. This technology, which has been around for decades but has only recently come to the forefront on a...
ONVO: 4.45 (-0.25)

Bioprinting Profits: Why Organovo’s 3-D Bioprinting Technology Isn’t Worth Investment
at The Street - Mon Feb 09, 4:19PM CST
3D bioprinting technology sounds cool and actually works, but can it help Organovo make money?
ONVO: 4.45 (-0.25)

Organovo Holdings EPS and revenue in-line
Seeking Alpha - at Seeking Alpha - Mon Feb 09, 7:41AM CST

ONVO: 4.45 (-0.25)

Organovo Holdings, Inc. Reports Third Quarter Results
PR Newswire - Mon Feb 09, 7:05AM CST
Organovo Holdings, Inc. (NYSE MKT: ONVO) ("Organovo"

, a three-dimensional biology company focused on delivering pioneering 3D bioprinting technology, has reported its third quarter fiscal 2015 results.
ONVO: 4.45 (-0.25)

3 Medical Advancements You May Be Missing Out On
Motley Fool Staff - Motley Fool - Sun Feb 08, 10:02AM CST
Source: 3D Systems. From 3D printing to next-generation cancer killers, there are some medical innovations that could have an incredible impact on patients. Our Motley Fool analysts explain how these next-generation medical advances could reshape...
BIIB: 420.48 (+7.13), ONVO: 4.45 (-0.25), DDD: 26.74 (-0.49), PFE: 34.46 (+0.46), MRK: 57.07 (+0.87), EPRS: 10.02 (+0.06), AMGN: 161.79 (+7.53), BMY: 67.84 (+0.97), NVS: 97.96 (+0.92), CELG: 120.44 (+2.71)

Global 3D Printing Market (Material, Technology, Application) Insights and Forecasts 2014-2022
M2 - Thu Feb 05, 6:01AM CST
Research and Markets (http://www.researchandmarkets.com/research/fzht79/3d_printing) has announced the addition of the "3D Printing Market (Material, Technology, Application): Global Insight (2014-2022)" report to their offering. The study refers to the market potential of 3D printing technology across the following major application verticals - Aerospace & Defense, Architecture, Automotive, Electronics, Education & Research, Healthcare, Oil & Gas Industry, Fashion & Jewelry, and Entertainment. In terms of materials, the report exhaustively covers Metals & Metal alloys, Polymers & Plastics, Ceramics, and Paper. Detailed analysis and forecasts along with specific user cases have been presented in the report. The report covers more than 50 major players involved in the 3D printing and Additive Manufacturing industries. The report presents a detailed market analysis of 3D printing and Additive Manufacturing by incorporating complete pricing and cost analysis of components & products, product benchmarking, Porter's analysis and PEST (Political, Economic, Social & Technological factors) analysis of the market. Market Classification encompasses segmentation & sub-segmentation of the market by Technology, Materials, Application Industry and Geography. The report deals with all the driving factors, restraints, and opportunities with respect to the 3D printing and Additive Manufacturing market, which are helpful in identifying trends and key success factors for the industry. The current market landscape is covered with detailed competitive landscape and company profiles of all key players across the ecosystem. The report also formulates the entire value chain of the market, along with industry trends of 3D printing application industries and materials used with emphasis on market timelines & technology roadmaps, and market & product life cycle analysis. Technology Analysis chapter provides detailed insights into existing 3D printing technologies such as FDM, SLS, 3DP, SLA, PJM, EBM, and Multijet modeling, among others. The information supplied in the chapter includes market players, market size, materials used, and growth opportunities, along with technology lifecycle analysis. Material Analysis includes market size and growth opportunity of principal materials such as plastics, photopolymers, ceramics, and wax, among others. Application Analysis presents detailed market statistics for different application verticals. The chapter enumerates various user cases and presents a futuristic roadmap for each industry vertical. Lastly, the 3D printing and Additive Manufacturing market is segmented by geography across North America, South & Central America, Europe, Asia-Pacific and ROW (Rest of the World) and further sub-segmented by countries. Country specific market is estimated and the growth opportunities are identified. Key Topics Covered: 1. Executive Summary 2. Report Scope 3. Market Overview 4 Technology Market 5 Materials Market 6 Applications Market 7 Geographic Analysis 8 Industrial Analysis 9 Competitive Landscape 10 Company Profiles - 3d Systems - 3t Rpd Ltd - Arcam Ab - Biomedical Modeling Inc - Ceradrop Mgi Group - Concept Laser - Dassault Syst?mes - Koninklijke Dsm Nv - Envisiontec - Eos Gmbh Electro Optical Systems - Exone - Gpi Prototype & Manufacturing Services, Inc - Hoganas Ab - Layerwise Nv - Luxexcel Group B.V - Mcor Technologies Ltd - Medical Modeling - Microtec Gesellschaft F?r Mikrotechnologie Mbh - Optomec - Organovo Holdings - Renishaw, Plc - Stratasys - Slm Solutions Gmbh - Voxeljet - Zortrax For more information visit http://www.researchandmarkets.com/research/fz...d_printing
ONVO: 4.45 (-0.25), SSYS: 57.65 (-0.14)

ONVO, PRLB, AMAVF join 3D printing stock rout
Seeking Alpha - at Seeking Alpha - Tue Feb 03, 9:06AM CST

ONVO: 4.45 (-0.25), PRLB: 70.15 (+0.20)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

PwC US and India Unite for Global Consultancy Powerhouse

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

Tam-Peli Steps Up in SCLC Battle: Trial Insights

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

First-Time Homeowners: Unseen Pitfalls of Insurance

Understanding Homeowners Insurance: Beyond the Basics Most folks diving into homeownership for the first time get caught up in the whirlwind of price tags, loans, and knick-knacks for their new place. Meanwhile, the nitty-gritty of homeowners insurance often gets tossed to the side. But take it from a weary watchdog of financial storms—it’s those details in the policy...

GORGIE Unleashes Berry Burst: Target's New Drink Star

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...

UWM Faces Class Action Deadline: Key Insights for Investors

The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...

Ris-Rez May Set New Standard in Relapsed SCLC

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

MRI Surveillance Gains Ground in Lung Cancer Care

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....

Trial Disappointment: No Significant Gains in NSCLC

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...